2 most recent filings and news items mentioning CELC. Updated every 60 seconds.
OfferingJun 16, 2026Neutral
CEL-SCI Corporation has entered into a placement agency agreement with ThinkEquity LLC to act as exclusive placement agent for an offering of up to 2,500,000 shares of common stock at $1.00 per share. The offering will be conducted on a reasonable best efforts basis with closing
View filing at SEC.gov →
RegulatoryJun 2, 2026Positive
Celcuity announced positive Phase 3 VIKTORIA-1 trial results showing gedatolisib combination regimens reduced disease progression risk by 50% compared to alpelisib in PIK3CA mutant HR+/HER2- breast cancer patients. The results represent a potential major advancement for the compa
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.